Those whove tried oral supplements without experiencing symptom improvement should consider injection therapy
Some people remain at 1.7mg if side effects at 2.4mg are too disruptive
Women Tend to Lose More Weight on GLP-1s Than Men We looked at lots of different factors that might be plausibly associated with efficacy of these products, and sex was the only one of the five or six that we looked at where we found significantly different effects, says coauthor Caleb Alexander, MD, an internist, epidemiologist, and co-director of the Center for Drug Safety and Effectiveness at Johns Hopkins Medicine in Baltimore
Ensure you are spacing injections at least one inch apart and avoiding the same site for at least seven days between doses
Risk factors that may influence the decision to pause treatment include: Being in the dose-escalation phase of GLP-1 therapy Experiencing active gastrointestinal symptoms (nausea, vomiting, bloating) Having known gastroparesis or other conditions affecting gastric emptying Taking concurrent medications that further delay gastric emptying (e.g., opioids) Undergoing procedures with higher aspiration risk (e.g., emergency surgery, airway surgery) If your anaesthetist or surgical team advises temporary cessation based on your individual risk assessment, the timing will depend on the specific medication: Daily injections (such as liraglutide): Typically paused 24 hours before surgery Weekly injections (such as semaglutide, dulaglutide): Often paused with the last dose given at least 7 days before surgery Oral semaglutide (Rybelsus): Usually paused 24 hours before surgery However, these timings may vary according to local NHS Trust protocols and individual clinical assessment
Artificial intelligence in early drug discovery enabling precision medicine
